The global benign prostatic hyperplasia market is estimated to grow at a CAGR of around 7% during the forecast period. Benign prostatic hyperplasia (BPH), is a condition in which men’s prostate gland gets enlarged, though not cancerous. Benign prostatic hyperplasia is also named as benign prostatic hypertrophy or benign prostatic obstruction. Men’s prostate gland gets enlarged mainly in two stages, first occurs during puberty, and second-growth occurs around age 25 and continues during most of a man’s life. This BPH mainly occurs during the second-growth phase. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), BPH is among the common prostate problem for men, who are older than age 50, and in 2010 in the US, nearly 14 million men had BHP symptoms. BPH affects nearly 50% of men between the ages of 51-60 and 90% of men age above 80.

Free Sample Copy @ https://www.omrglobal.com/request-sample/benign-prostatic-hyperplasia-treatment-market

The global benign prostatic hyperplasia treatment market is segmented based on treatment type. Based on the treatment type, the market is segmented into medications, minimally invasive procedures, laser therapy, and others. Based on medications,it is segmented into alpha-blockers, 5 alpha-reductase inhibitors (ARIs), a phosphodiesterase-5 enzyme inhibitor, and others. Based on minimally invasive procedures, it is segmented into transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP), transurethral microwave thermotherapy (TUMT), and Transurethral Needle Ablation (TUNA). Based on laser therapy, it is segmented into ablative procedures and enucleation procedures.

A Full Report of Global Benign Prostatic Hyperplasia Treatment Market is Available at:
https://www.omrglobal.com/industry-reports/benign-prostatic-hyperplasia-treatment-market

The rising frequency of benign prostatic hyperplasia is the key factor, which is a major driver of this market growth. Besides, public awareness, the government initiatives, an increase in health budget are also driving the global benign prostatic hyperplasia market growth. Researchers found that there is an alarmingly increasing rate of benign prostatic hyperplasia among the middle-aged and old-aged men. Since people are less aware of the BHP, many country's governments are launching many awareness campaigns to spread awareness about BPH symptoms and treatment. For instance, the US health advocate and health authorities conduct prostate health awareness campaign the “National Prostate Health Month” every year in September, to educate the people about the risk and treatment, that are associates with benign prostatic hyperplasia.

Sometimes many patients suffered several types of side effects after benign prostatic hyperplasia treatment. After BPH surgery some patients suffer from urinary incontinence, discomfort during urination, and difficulty in completely emptying the bladder and others. For these side effects many patients who are suffering from BHP, don’t prefer BPH surgeries, resulting in decreasing demand for surgical devices. These side effects are the major restraints of this market growth. Technological innovation is a major opportunity of the global benign prostatic hyperplasia treatment market, such as innovation of laser therapy is among them.

Global Benign Prostatic Hyperplasia Treatment Market -- Segmentation
by Treatment

Medications
Alpha-blockers
5 Alpha reductase inhibitor (ARIs)
Phosphodiesterase-5 Enzyme Inhibitor
Others
Minimally Invasive Procedures
Transurethral Resection of the Prostate (TURP)
Transurethral Incision of the Prostate (TUIP)
Transurethral Microwave Thermotherapy (TUMT)
Transurethral Needle Ablation (TUNA)
Laser Therapy
Ablative procedures
Enucleation procedures
Others (Surgery, Prothetic urethral lift, Embolization)

Global Benign Prostatic Hyperplasia Treatment Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Abbott Laboratories
Allergan, Inc.
Astellas Pharma, Inc.
Boehringer Ingelheim GmbH
Boston Scientific Corp.
Camber Pharmaceuticals, Inc.
Coloplast A/S
Daiichi Sankyo Co., Ltd.
Eli Lilly &Co.
Endo International PLC
GlaxoSmithKline PLC
Karl Storz GmbH& Co.Kg
Lumenis, Ltd.
Merck & Co., Inc.
Nymox Pharmaceutical Corp.
Olympus Corp.
Pfizer, Inc.
ProArc Medical, Ltd.
Sanofi S.A.
Sophiris Bio Corp.
Sun Pharmaceutical Industries, Ltd.
Synthon B.V.
Teva Pharmaceutical Industries, Ltd.
Urologix, Inc.
Veru, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/benign-prostatic-hyperplasia-treatment-market


About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404